Journal article
Body Composition, Natriuretic Peptides, and Adverse Outcomes in Heart Failure With Preserved and Reduced Ejection Fraction
JACC. Cardiovascular imaging, Vol.14(1), pp.203-215
01/01/2021
DOI: 10.1016/j.jcmg.2020.07.022
PMCID: PMC7796896
PMID: 32950445
Abstract
OBJECTIVES The purpose of this study was to determine the relationship between body composition, N-terminal B-type natriuretic peptide (NT-proBNP) levels, and heart failure (HF) phenotypes and outcomes.
BACKGROUND Abnormalities in body composition can influence metabolic dysfunction and HF severity; however, data assessing fat distribution and skeletal muscle (SM) size in HF with reduced (HFrEF) and preserved EF (HFpEF) are limited. Further, whether NPs relate more closely to axial muscle mass than measures of adiposity is not well studied.
METHODS We studied 572 adults without HF (n = 367), with HFrEF (n = 113), or with HFpEF (n = 92). Cardiac magnetic resonance was used to assess subcutaneous and visceral abdominal fat, paracardial fat, and axial SM size. We measured NT-proBNP in 334 participants. We used Cox regression to analyze the relationship between body composition and mortality.
RESULTS Compared with controls, pericardial and subcutaneous fat thickness were significantly increased in HFpEF, whereas patients with HFrEF had reduced axial SM size after adjusting for age, sex, race, and body height (p < 0.05 for comparisons). Lower axial SM size, but not fat, was significantly predictive of death in unadjusted (standardized hazard ratio: 0.63; p < 0.0001) and multivariable-adjusted analyses (standardized hazard ratio = 0.72; p = 0.0007). NT-proBNP Levels more closely related to lower axial SM rather than fat distribution or body mass index (BMI) in network analysis, and when simultaneously assessed, only SM (p = 0.0002) but not BMI (p = 0.18) was associated with NT-proBNP. However, both NT-proBNP and axial SM mass were independently predictive of death (p < 0.05).
CONCLUSIONS HFpEF and HFrEF have distinct abnormalities in body composition. Reduced axial SM, but not fat, independently predicts mortality. Greater axial SM more closely associates with lower NT-proBNP rather than adiposity. Lower NT-proBNP levels in HFpEF compared with HFrEF relate more closely to muscle mass rather than obesity. (C) 2021 by the American College of Cardiology Foundation.
Details
- Title: Subtitle
- Body Composition, Natriuretic Peptides, and Adverse Outcomes in Heart Failure With Preserved and Reduced Ejection Fraction
- Creators
- Senthil Selvaraj - Hospital of the University of PennsylvaniaJessica Kim - Hospital of the University of PennsylvaniaBilal A. Ansari - Hospital of the University of PennsylvaniaLei Zhao - Bristol-Myers Squibb (United States)Mary Ellen Cvijic - Bristol-Myers Squibb (United States)Matthew Fronheiser - Bristol-Myers Squibb (United States)Jagan Mohan-Rao Vanjarapu - Hospital of the University of PennsylvaniaAnupam A. Kumar - Vanderbilt University Medical CenterArpita Suri - Hospital of the University of PennsylvaniaSowjanya Yenigalla - Hospital of the University of PennsylvaniaVaibhav Satija - Hospital of the University of PennsylvaniaArmghan Haider Ans - Hospital of the University of PennsylvaniaOffdan Narvaez-Guerra - Hospital of the University of PennsylvaniaKarela Herrera-Enriquez - Hospital of the University of PennsylvaniaMary Jo Obeid - Hospital of the University of PennsylvaniaJonathan J. Lee - University of PennsylvaniaQasim Jehangir - Hospital of the University of PennsylvaniaDietmar A. Seiffert - Bristol-Myers Squibb (United States)Bruce D. Car - Bristol-Myers Squibb (United States)David A. Gordon - Bristol-Myers Squibb (United States)Julio A. Chirinos - Hosp Univ Penn, Philadelphia, PA 19104 USA
- Resource Type
- Journal article
- Publication Details
- JACC. Cardiovascular imaging, Vol.14(1), pp.203-215
- DOI
- 10.1016/j.jcmg.2020.07.022
- PMID
- 32950445
- PMCID
- PMC7796896
- NLM abbreviation
- JACC Cardiovasc Imaging
- ISSN
- 1936-878X
- eISSN
- 1876-7591
- Publisher
- Elsevier
- Number of pages
- 13
- Grant note
- 2020061 / Doris Duke Charitable Foundation; Doris Duke Charitable Foundation (DDCF) Bristol-Myers Squibb NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA R01 HL 121510-01A1; 5-R21-AG-043802-02 / National Institutes of Health (NIH); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA department of Veterans Affairs; US Department of Veterans Affairs Fukuda-Denshi Measey Foundation, Institute for Translational Medicine and Therapeutics (Junior Investigator Preliminary/Feasibility Grant Program award) American Society of Nuclear Cardiology (Institute for the Advancement of Nuclear Cardiology award) R01-HL 121510-01A1; R61-HL-146390; R01AG058969; 1R01-HL104106; P01-HL094307; R03-HL146874-01; R56-HL136730 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA 5-T32HL007843-23 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Language
- English
- Date published
- 01/01/2021
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984845668702771
Metrics
3 Record Views